- Home
- FUTU vs ICUCW Comparison
FUTU vs ICUCW Comparison
Compare FUTU & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUTU
- ICUCW
- Stock Information
- Founded
- FUTU 2011
- ICUCW N/A
- Country
- FUTU Hong Kong
- ICUCW United States
- Employees
- FUTU N/A
- ICUCW 19
- Industry
- FUTU Investment Bankers/Brokers/Service
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- FUTU Finance
- ICUCW Health Care
- Exchange
- FUTU Nasdaq
- ICUCW Nasdaq
- Market Cap
- FUTU N/A
- ICUCW N/A
- IPO Year
- FUTU 2019
- ICUCW 2021
- Fundamental
- Price
- FUTU $121.50
- ICUCW N/A
- Analyst Decision
- FUTU Strong Buy
- ICUCW
- Analyst Count
- FUTU 4
- ICUCW 0
- Target Price
- FUTU $136.23
- ICUCW N/A
- AVG Volume (30 Days)
- FUTU 1.9M
- ICUCW N/A
- Earning Date
- FUTU 08-19-2025
- ICUCW N/A
- Dividend Yield
- FUTU 1.60%
- ICUCW N/A
- EPS Growth
- FUTU 58.31
- ICUCW N/A
- EPS
- FUTU 6.00
- ICUCW N/A
- Revenue
- FUTU $1,788,948,850.00
- ICUCW N/A
- Revenue This Year
- FUTU $48.73
- ICUCW N/A
- Revenue Next Year
- FUTU $9.97
- ICUCW N/A
- P/E Ratio
- FUTU $20.28
- ICUCW N/A
- Revenue Growth
- FUTU 54.51
- ICUCW N/A
- 52 Week Low
- FUTU $51.80
- ICUCW N/A
- 52 Week High
- FUTU $130.88
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- FUTU 58.15
- ICUCW N/A
- Support Level
- FUTU $117.78
- ICUCW N/A
- Resistance Level
- FUTU $126.00
- ICUCW N/A
- Average True Range (ATR)
- FUTU 4.97
- ICUCW 0.00
- MACD
- FUTU -0.06
- ICUCW 0.00
- Stochastic Oscillator
- FUTU 67.97
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.